Cargando…

Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes

PURPOSE: Suboptimal glycemic control among individuals with diabetes is a leading cause of hospitalizations and emergency department utilization. Use of flash continuous glucose monitoring (flash CGM) improves glycemic control in type 1 and type 2 diabetes, which may result in lower risk for acute a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergenstal, Richard M, Kerr, Matthew S D, Roberts, Gregory J, Souto, Diana, Nabutovsky, Yelena, Hirsch, Irl B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901259/ https://www.ncbi.nlm.nih.gov/pubmed/33644623 http://dx.doi.org/10.1210/jendso/bvab013

Ejemplares similares

Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy
por: Wright, Eugene E., et al.
Publicado: (2021)

Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
por: Sofizadeh, Sheyda, et al.
Publicado: (2019)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

Abstract 141: CGM-based measurements for once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-treated patients with type 2 diabetes: A post hoc analysis
por: Chandrappa, Manu, et al.
Publicado: (2022)

The Association Between HbA(1c) and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
por: Seyed Ahmadi, Shilan, et al.
Publicado: (2020)

Hypoglycemia event prediction from CGM using ensemble learning
por: Fleischer, Jesper, et al.
Publicado: (2022)

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
por: Moser, Othmar, et al.
Publicado: (2020)

Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial
por: Hásková, Aneta, et al.
Publicado: (2020)

Using Flash Continuous Glucose Monitoring in Primary Practice
por: Hirsch, Irl B., et al.
Publicado: (2019)

Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen
por: Galindo, Rodolfo J., et al.
Publicado: (2020)

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
por: Rosenstock, Julio, et al.
Publicado: (2008)

Cost-Effectiveness Analysis of Flash Glucose Monitoring System for People with Type 2 Diabetes Receiving Intensive Insulin Treatment
por: Ajjan, Ramzi, et al.
Publicado: (2022)

Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
por: Sato, Tatsuya, et al.
Publicado: (2018)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

Case-control Investigation of Previously Undiagnosed Diabetes in the Critically Ill
por: Krinsley, James S, et al.
Publicado: (2022)

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx
por: Lozada Orquera, Faustina Alejandra, et al.
Publicado: (2021)

Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes
por: Ni, Kevin, et al.
Publicado: (2023)

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking
por: Aleppo, Grazia, et al.
Publicado: (2023)

Targeting Technology in Underserved Adults With Type 1 Diabetes: Effect of Diabetes Practice Transformations on Improving Equity in CGM Prescribing Behaviors
por: Mathias, Priyanka, et al.
Publicado: (2022)

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes
por: Pettus, Jeremy, et al.
Publicado: (2016)

Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps
por: Kao, Kalvin, et al.
Publicado: (2021)

Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke
por: Boriani, Giuseppe, et al.
Publicado: (2023)

SAT134 CGM Use During Pregnancy Complicated By CF-Induced Diabetes
por: Mazori, Alon Y, et al.
Publicado: (2023)

Erratum. Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective. Diabetes Care 2018;41:1125–1131
por: Beran, David, et al.
Publicado: (2018)

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
por: Reddy, Monika, et al.
Publicado: (2018)

Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
por: Krajnc, Mitja, et al.
Publicado: (2023)

Insulin in America: A Right or a Privilege?
por: Hirsch, Irl B.
Publicado: (2016)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
por: Senn, Jon-Duri, et al.
Publicado: (2019)

Management of Hyperglycemia in Diabetic Kidney Disease
por: Neumiller, Joshua J., et al.
Publicado: (2015)

A new look at brittle diabetes()
por: Hirsch, Irl B., et al.
Publicado: (2021)

Making Sense of BGM and CGM Data for a Basal-Bolus Insulin User
Publicado: (2020)

Benefits and Drawbacks of Continuous Glucose Monitoring (CGM) Use in Young Children With Type 1 Diabetes: A Qualitative Study From a Country Where the CGM Is Not Reimbursed
por: Karakuş, Kağan Ege, et al.
Publicado: (2021)

PSUN229 Transitions of Care and Readmissions in Patients with Diabetes Receiving CGM at Hospital Discharge
por: Barnett, Anne, et al.
Publicado: (2022)

SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
por: Totomirova, Tzvetelina, et al.
Publicado: (2023)

A Novel CGM Metric-Gradient and Combining Mean Sensor Glucose Enable to Improve the Prediction of Nocturnal Hypoglycemic Events in Patients with Diabetes
por: Li, Jingzhen, et al.
Publicado: (2020)

Home Blood Glucose Monitoring in Type 2 Diabetes: Broken health care system undermines study's impact
por: Hirsch, Irl B.
Publicado: (2011)

Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes
por: Poolsup, Nalinee, et al.
Publicado: (2013)

A systematic bibliometric analysis on the clinical practice of CGM in diabetes mellitus from 2012 to 2022
por: Kong, Laixi, et al.
Publicado: (2023)

Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications
por: Manfredo, Jacquelyn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88t1ipeafkrl20qep2u7b9aj93